Stocks and Finance

Threshold Pharmaceuticals

Threshold Pharmaceuticals 4/11/2012

06:53 : Threshold Pharmaceuticals (THLD) earns a $20M milestone payment from Merck - Threshold Pharmaceuticals (THLD) earns a $20M milestone payment from Merck KGaA (MKGAF.PK). The payment was tied to performance of its TH-302 pancreatic cancer treatment candidate in a Phase 2 trial. Post ...
Source : seekingalpha-com

Threshold Pharmaceuticals 3/30/2012

18:20 : Threshold Pharmaceuticals ([[THLD]] +4.5%), which rallied today after ... - Threshold Pharmaceuticals (THLD +4.5%), which rallied today after its TH-302 drug received orphan status from the FDA, falls 2.3% AH after providing detailed clinical results for the drug's Phase 2b trials, which evaluate ...
Source : seekingalpha-com
06:34 : Threshold Pharmaceuticals Receives US Orphan Drug Designation for TH-302 ... - SOUTH SAN FRANCISCO, CA--(Marketwire - Mar 30, 2012) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for TH-302, a hypoxia-targeted ...
Source : marketwire-com

Threshold Pharmaceuticals 3/16/2012

07:01 : Threshold Pharmaceuticals (THLD) receives orphan drug designation in the ... - Threshold Pharmaceuticals (THLD) receives orphan drug designation in the EU for its TH-302 treatment for soft tissue sarcoma after early studies showed positive results with patients. The company is currently in critical ...
Source : seekingalpha-com

Threshold Pharmaceuticals 3/12/2012

06:39 : Threshold Pharmaceuticals' TH-302 to Be Featured at Symposium on Hypoxia ... - SOUTH SAN FRANCISCO, CA--(Marketwire - Mar 12, 2012) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) announced that TH-302 will be featured among several presentations by academic and industry experts at a symposium entitled ...
Source : marketwire-com

Threshold Pharmaceuticals 3/6/2012

05:38 : Threshold Pharmaceuticals Announces Oral Presentation on TH-302 Clinical ... - SOUTH SAN FRANCISCO, CA--(Marketwire - Mar 6, 2012) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that a Late-Breaking clinical abstract has been selected for presentation at the American Association ...
Source : marketwire-com

Threshold Pharmaceuticals 2/3/2012

07:42 : Shares of Threshold Pharmaceuticals (THLD) skyrocket, up 62.1%, after ... - Shares of Threshold Pharmaceuticals (THLD) skyrocket, up 62.1%, after the biotech firm announces that it landed a deal with Merck KGaA (MKGAF.PK) to co-develop and commercialize its TH-302 cancer treatment ...
Source : seekingalpha-com

Threshold Pharmaceuticals 12/14/2011

05:23 : Threshold Pharmaceuticals Announces Promising Phase 1 Clinical Trial Result - SOUTH SAN FRANCISCO, CA--(Marketwire - Dec 14, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced clinical trial results of the Phase 1 study of TH-302 in patients with advanced leukemias conducted ...
Source : marketwire-com

Threshold Pharmaceuticals 12/13/2011

05:18 : Threshold Pharmaceuticals Announces Update to TH-302 Pancreatic Data to ... - SOUTH SAN FRANCISCO, CA--(Marketwire - Dec 13, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present an update at the ...
Source : marketwire-com

Threshold Pharmaceuticals 11/29/2011

05:53 : Threshold Pharmaceuticals to Present at the Oppenheimer Healthcare Conferen - SOUTH SAN FRANCISCO, CA--(Marketwire - Nov 29, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at the 2011 Oppenheimer ...
Source : marketwire-com

Threshold Pharmaceuticals 9/6/2011

11:29 : Threshold Pharmaceuticals to Present at Rodman & Renshaw 13th Annual Health - REDWOOD CITY, CA--(Marketwire - Sep 6, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at the Rodman and Renshaw|Rodman ...
Source : marketwire-com
actualidad Threshold Pharmaceuticals -


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts